Gene therapy restores muscle strength in Duchenne muscular dystrophy

via Wikipedia

Researchers from Genethon, the AFM-Téléthon laboratory, Inserm (UMR 1089, Nantes) and the University of London (Royal Holloway) demonstrated the efficacy of an innovative gene therapy in the treatment of Duchenne muscular dystrophy. Indeed, after injecting microdystrophin (a “shortened” version of the dystrophin gene) via a drug vector, the researchers managed to restore muscle strength and stabilise the clinical symptoms in dogs naturally affected by Duchenne muscular dystrophy.

This work published in Nature Communications has been achieved thanks to the donations of the French Téléthon.

Teams at Genethon developed, in collaboration with a team at Royal Holloway University of London led by Pr. Dickson, and produced, a gene therapy drug combining an AAV-type viral vector with a shortened version of the dystrophin gene (approximately 4,000 base pairs), allowing the production of a functional protein. Dr Le Guiner’s team tested this innovative treatment in 12 dogs naturally affected by Duchenne muscular dystrophy. By injecting this microdystrophin intravenously, and hence into the whole body of the dogs, the researchers observed that dystrophin expression returned to a high level, and muscle function was significantly restored, with stabilisation of the clinical symptoms observed for over 2 years following injection of the drug. No immunosuppressive treatment was administered beforehand, and no sideeffects were observed.

Some Golden Retrievers develop Duchenne muscular dystrophy naturally. The successful treatment of these dogs, which show the same clinical symptoms as children with this disease, and are of a similar weight, is a decisive step toward developing the same treatment in children. “This preclinical study demonstrates the safety and efficacy of microdystrophin, and makes it possible to consider developing a clinical trial in patients. Indeed, this is the first time that it has been possible to treat the whole body of a large sized animal with this protein. Moreover, this innovative approach allows treatment of all patients with Duchenne muscular dystrophy, regardless of the genetic mutation responsible,” says Caroline Le Guiner, the main author of this study.

Learn more: Gene therapy: Microdystrophin restores muscle strength in Duchenne muscular dystrophy

The Latest on: Duchenne muscular dystrophy

[google_news title=”” keyword=”Duchenne muscular dystrophy” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]

Derbyshire family praises support for boy, three, with rare disorder
on April 1, 2023 at 1:12 am
Lincoln, three, from Overseal, Derbyshire, was diagnosed with a rare muscular degenerative disorder called Duchenne muscular dystrophy. There is no treatment for the condition. However, the family ...
Satellos Bioscience Announces 2022 Year End Financial Results and Operational Highlights
on March 30, 2023 at 6:56 pm
Satellos Bioscience Inc. (TSXV:MSCL) (OTCQB:MSCLF) ("Satellos" or the "Company"), a drug discovery company developing small molecule therapeutics to regenerate muscle ...
India exempts import tax on pricey rare disease medicines
on March 30, 2023 at 1:43 am
The Indian government said on Thursday it was providing a full exemption from basic customs duty for rare disease therapies and Merck & Co Inc's cancer therapy Keytruda when such medicines were ...
Duchenne Muscular Dystrophy Sales Market 2023-2031 with Driving Factors
on March 28, 2023 at 8:02 am
Mar 28, 2023 (The Expresswire) -- Duchenne Muscular Dystrophy Sales Market research report aims to provide valuable insights and a regional outlook for future market growth estimations.
2023 to 2030 Duchenne Muscular Dystrophy Treatment Market Installation, Application and Type
on March 28, 2023 at 12:17 am
Mar 27, 2023 (The Expresswire) -- “Duchenne Muscular Dystrophy Treatment Market” Are a Collection of Information and Analysis Obtained From Diverse Sources to Aid Businesses in Comprehending ...
Where there’s a will, there’s Fenway
on March 28, 2023 at 12:00 am
Our 3-year-old son has a rare genetic disease. I search for an angle into this sad story where he might defeat the beast. The promise of victory is an uphill climb, to be sure — but possible. Within ...
Why the world’s smallest wheelchairs are going unused
on March 27, 2023 at 1:31 am
What do you do when the years of fundraising and lobbying and research actually pay off? At the Dallas conference, Duchenne muscular dystrophy researchers and patient advocates contemplated a similar ...
Duchenne Muscular Dystrophy (DMD): Parents of affected children to spread awareness at Jantar Mantar on Friday
on March 23, 2023 at 10:17 am
Duchenne Muscular Dystrophy disease or DMD is a hereditary disorder that commonly affects boys and is one of the most several forms of muscular dystrophies. To spread awareness about it, parents of ...
What is Duchenne Muscular Dystrophy? Rally to raise awareness for DMD treatment in Delhi
on March 23, 2023 at 5:17 am
For the first time, hundreds of parents from all over India, who’ve been fighting a lonely battle against this dreaded disease, will come together at Jantar Mantar to tell you more about our fight ...
Duchenne Muscular Dystrophy Therapeutics Market 2023 With SWOT Study, Include Competative Analysis Upto 2028
on March 20, 2023 at 1:18 pm
The latest research study released byIndustry Research Biz on “Duchenne Muscular Dystrophy Therapeutics Market” with analysis on business strategy taken up by emerging industry players ...